VITURA Health has established an unincorporated joint venture (JV) with Australian-based Releaf Group which is expected to increase the volume of medicinal cannabis products prescribed and distributed through the CanView platform, the number of patients and prescribers registered, and using the platform's functionality.
Under the terms of the JV agreement, Vitura will provide Releaf, including its franchisees, a Releaf-branded version of Vitura's CanView platform for exclusive use by Releaf's prescribing doctors, dispensaries and patients.
The CanView platform may benefit Releaf by increasing workflow efficiencies, better compliance reporting, and be a turnkey operating solution for new franchisees.
In turn the JV provides Vitura with exposure to Releaf's physical location business model in high foot traffic locations.
Vitura CEO, Rodney Cocks, shared that he is excited to see "the CanView platform being favoured as the complete end-to-end technology solution, and working closely with Releaf to build on their leading position in the physical location clinical space providing better service through the CanView platform."
Gary Mackenzie, CEO of Releaf, said he is pleased to partner with Vitura and integrate its CanView platform into Releaf clinical services and dispensaries.
"This JV will enhance our workflow efficiencies, compliance reporting and provide a turnkey solution for new franchisees.
"We are excited to offer our patients a seamless experience with the Releaf-branded CanView platform and access to a wider range of medical cannabis products, including the iconic North American brand Cookies."
This is the first deployment of the CanView platform with the backing of two distribution centres in Melbourne and on the Gold Coast.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 May 23
